Satellite Symposia

DAY 1: Thursday, July 7, 2016

National Psoriasis Foundation Symposium
 

"Complex cases in psoriasis"

10:00 - 11:30 - Room 251

Presenter:

Jeffrey Weinberg, MD
Mount Sinai School of Medicine
New York, NY, USA 

Agenda:

1. Interactive Presentation (~30 minutes)
• Commonalities in the pathophysiology of psoriasis and comorbid conditions
• Integrating techniques, technologies and tools that support earlier recognition and aggressive treatment of psoriasis and psoriatic arthritis
• Safety, efficacy and the role of current systemic psoriasis treatments in addressing skin, joint and cardiometabolic symptoms in patients with complex presentations
• Review of emerging drugs
• Applying a patient-centric approach to pursuing treatment goals in patients with complex psoriasis presentations

2. Complex Cases (~45 minutes)
• Complex patient 1: Patient who has failed previous biologic therapy
• Complex patient 2: Woman of child‑bearing age
• Complex patient 3: Patient with cardiovascular comorbidities
• Complex patient 4: Immunocompromised patient

3. Summary, Conclusions and Q&A (~15 minutes)


DAY 2: Friday, July 8, 2016

Abbvie Symposium


"PsOACT: A lifetime of comprehensive and personalized psoriasis care”

12:45 - 14:15 - Room 252AB

Chair:

Professor Kristian Reich (Germany)

Presenters:

Professor Wolf-Henning Boehncke (Switzerland)
Professor Matthias Augustin (Germany)

Agenda:

Welcome and introduction – Kristian Reich (Hamburg, Germany)
Achieving a patient-focused approach to care – Matthias Augustin (Hamburg, Germany)
Creating lifelong personalized care – Kristian Reich (Hamburg, Germany)
Taking a comprehensive approach to manage psoriasis – Wolf-Henning Boehncke (Geneva, Switzerland)
Discussion and audience Q&A



Janssen Pearls Symposium
 

"Cognitive consequences: understanding the link between psoriasis and psychiatric comorbidities"

12:45 - 14:15 - Amphitheatre Bleu

Agenda:

1. Welcome and introduction - Professor Peter van de Kerkhof 
2. The complexity of psoriasis: a systemic disease - Professor Peter van de Kerkhof
3. Risk factors for cognitive impairment in patients with psoriasis - Professor Paolo Gisondi
4. Alexithymia and the burden of psoriasis: outcomes from the EPIDEPSO study - Professor Carle Paul
5. Questions and closing remarks - All
 



A Medscape Education Symposium*

"Il-17a and Psoriasis Management : State of the Art"

12:45 - 14:15 - Room Maillot

Chair:
Craig Leonardi, MD (Chair)
Clinical Professor of Dermatology, St. Louis
University Medical School,
Missouri

Presenters:
 

Denis Jullien, MD, PhD
Professor, Department of Dermatology at Hôpital Edouard Herriot,
Université Claude Bernard
Lyon, France

Richard Langley, MD, FRCPC
Professor, Department of Medicine, Division of Clinical Dermatology & Cutaneous Science, Dalhousie
University, Halifax, Nova Scotia

Ulrich Mrowietz, MD
Head of Psoriasis-Center,
Dept. of Dermatology, Venerology and Allergology, University Medical Center
Schleswig-Holstein,
Campus Kiel, Germany

Agenda:

Introduction
Craig Leonardi, MD

Psoriasis: Pathology Beyond the Skin
Denis Jullien, MD, PhD

IL-17a Inhibition in Psoriasis Therapy:
State of the Art

Ulrich Mrowietz, MD 

Treating to Target in Psoriasis:
What Is the Target?
Richard Langley, MD, FRCPC

Evidence into Action: Case Discussions
Craig Leonardi, MD

Panel Discussion and Conclusion
Craig Leonardi, MD 

*Supported by an Independent Educational Sponsorship from Eli Lilly


 
Novartis Symposium

"Expanding treatment horizons for patients with psoriasis and psoriatic arthritis"

16:30 - 18:00 - Amphitheatre Bleu

Agenda:

1. Welcome and introduction - Hervé Bachelez (Paris, France, chair)
2. Evolving psoriasis treatment options - Sandra Philipp (Berlin, Germany)
3. Current challenges and future propects in hard-to-treat psoriasis - Curdin Conrad (Lausanne, Switzerland)
4. Beyond the skin: Joint involvement in psoriatic disease - Dominique Baeten (Amsterdam, The Netherlands)
5. Sharing best practice with Clinical Cases - All (chair to moderate)
6. Question and answer session - All (chair to moderate)
7. Summary and conclusions - Chair

12.45–12.55

Welcome and introduction

Kristian Reich

Hamburg, Germany